Monoclonal Antibodies + Rozanolixizumab Interaction

Moderateinteraction on record

Description

Concomitant use may lower systemic exposures and reduce effectiveness of monoclonal antibodies. Closely monitor for reduced effectiveness.

Mechanism

Competition for human neonatal Fc receptor (FcRn) binding

Source: NLP:rozanolixizumab

Related drug profiles

All Monoclonal Antibodies interactions →All Rozanolixizumab interactions →
Share this page:XFacebookWhatsAppReddit